T-3775440-hydrochloride _Histone Demethylase 抑制剂 - MedChemExpress_第1页
T-3775440-hydrochloride _Histone Demethylase 抑制剂 - MedChemExpress_第2页
T-3775440-hydrochloride _Histone Demethylase 抑制剂 - MedChemExpress_第3页
T-3775440-hydrochloride _Histone Demethylase 抑制剂 - MedChemExpress_第4页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemET-3775440 hydrochlorideCat. No.: HY-103085CAS No.: 1422535-52-1分式: CHClNO分量: 346.85作靶点: Histone Demethylase作通路: Epigenetics储存式: 4C, sealed storage, away from moisture* In solvent : -80C, 6 months; -20C, 1 month (sealedstorage, a

2、way from moisture)溶解性数据体外实验 DMSO : 30.18 mg/mL (87.01 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 2.8831 mL 14.4155 mL 28.8309 mL5 mM 0.5766 mL 2.8831 mL 5.7662 mL10 mM 0.2883 mL 1.4415 mL 2.8831 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。体内实验 请根据

3、您的实验动物和给药式选择适当的溶解案,配制前请先配制澄清的储备液,再依次添加助溶剂(为保证实验结果的可靠性,体内实验的作液,建议您现现配,当天使;澄清的储备液可以根据储存条件,适当保存;以下溶剂前的百分 指该溶剂在您配制终溶液中的体积占):1. 请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (7.21 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (7.21

4、mM); Clear solution3. 请依序添加每种溶剂: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (7.21 mM); Clear solution1/3 Master of Small Molecules 您边的抑制剂师www.MedChemEBIOLOGICAL ACTIVITY物活性 T-3775440 (hydrochloride)种赖氨酸特异性脱甲基酶1 (LSD1) 的不可逆性抑制剂,其 IC50 值为 2.1 nM。IC50 & Target IC50: 2.1 nM (LSD1) 1.体外研究 T-3775440 demon

5、strates irreversible inhibition of recombinant human LSD1, with a kinact/KI value of1.7105 (sec1 M1). T-3775440 is highly selective for LSD1 relative to other monoamine oxidases (e.g.,MAO-A and MAO-B), with an IC50 value of 2.1 nM). T-3775440 blocks the proliferation of several cell linesas quickly

6、as day 3 of treatment. Notably, the granulocyte/macrophage markers CD86 and CD11b arecommonly upregulated on both TF-1a and HEL92.1.7 cells in response to T-3775440 treatment, whereas theerythroid markers CD235a and CD71 are downregulated by this treatment. In CMK11-5 cells, CD86 mRNAexpression is a

7、lso clearly upregulated by T-3775440 in a concentration-dependent manner, although only amodest increase in cell surface CD86 expression is observed. T-3775440 treatment disrupts the LSD1-GFI1B association in a concentration-dependent manner. T-3775440 decreases LSD1 binding but not GFI1Bbinding and

8、 increases the level of dimethylated H3K4 at the PI16 locus 1.体内研究 T-3775440 upregulates CD86 mRNA expression in tumor xenografts of HEL92.1.7 cells in a dose-dependentmanner following the oral administration of single doses ranging from 3 to 30 mg/kg. To investigate targetengagement of this compoun

9、d in tumors, PI16 expression levels is tested as a direct biomarker. Asexpected, PI16 suppression is dramatically reversed by T-3775440 treatment. In a TF-1a (AEL) tumorxenograft model, T-3775440 exhibits significant antitumor effects, with 15-day T/C values of 15.6% and 1.PROTOCOLCell Assay 1 The h

10、uman leukemia cell lines TF-1a, HEL92.1.7, CMK11-5 and M07e are used. All cells are grown inRPMI1640 plus 10% FBS and maintained in a humidified incubator at 37C and 5% CO2. To assess cellproliferation and viability in human leukemia cell lines, compounds (e.g T-3775440) are added with differentconc

11、entrations (T-3775440: 0, 10, 50 nM) at 24 h after cell seeding. After the incubation period, cells arelysed with CellTiter-Glo, and luminescent signals are detected using an ARVO MX1420 microplate reader.For cell-cycle analysis, cells are fixed overnight with 70% ethanol. Fixed cells are stained wi

12、th propidiumiodide and analyzed on a FACSCalibur or FACSVerse flow cytometer 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Mice 1Administration 1 Female C.B17/Icr-scid/scid Jcl mice are used and maintained under specific pathogen-free conditi

13、ons. AMLcells (2106 cells) in Matrigel are inoculated subcutaneously into the left flanks of 6- to 7-week-old mice (day0). Mice are randomized when the mean tumor volume reached approximately 150 to 350 mm3.Subsequently, mice are administrated with vehicle or T-3775440 single doses ranging from 3 to

14、 30 mg/kgonce daily on 5 days on/2 days off schedule for 2 weeks. Twice weekly, tumors are measured with verniercalipers, and tumor volumes are calculated 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.2/3 Master of Small Molecules 您边的抑制剂师www.MedChem

15、E户使本产品发表的科研献 Cancer Cell. 2019 Jul 9. pii: S1535-6108(19)30298-3.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Ishikawa Y, et al. A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and ImpairedGrowth of AML Cells. Mol Cancer Ther.

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论